a decreasing trendP< 0.05
However, the incidence and risk of hyperglycemia showed a decreasing trend with the increase of TSH, and the third quartile OR and 95%CI were 0.74 (0.59-0.93) (P< 0.05).
However, the incidence and risk of hyperglycemia showed a decreasing trend with the increase of TSH, and the third quartile OR and 95%CI were 0.74 (0.59-0.93) (P< 0.05).
The results showed that: With the increase of FT3 level, the incidence and risk of MS and its components showed an increasing trend, except for hyperglycemia.